
Subex wins ₹24-crore EAM contract from leading North African telecom operator
The 9-year project covers the deployment of Subex’s HyperSense solutions across the operator’s telecom network, fibre, IT, and data centre assets. Shares of Subex Ltd…

The 9-year project covers the deployment of Subex’s HyperSense solutions across the operator’s telecom network, fibre, IT, and data centre assets. Shares of Subex Ltd…

Shares of Varun Beverages Ltd ended at ₹406.50, down by ₹1.00, or 0.25%, on the BSE. On Monday (March 16), brokerage firm BoFA Securities maintained…

The company said the shutdown is a force majeure event and that it cannot quantify the impact at this stage. It is taking steps to…

Subsidiary CIPPL bags lowest bids worth ₹207 crore combined on Punjab e-procurement portal.

The e-auction was conducted by the government of Andhra Pradesh for the grant of a mining lease for the specified block. Shares of Shree Cement…

AstraZeneca Pharma India got CDSCO approval to market Durvalumab for unresectable hepatocellular carcinoma, expanding its oncology portfolio. Shares closed 0.33% higher at ₹8,403.

BEL secured orders worth ₹1,011 crore since Feb 25, 2026, including communication equipment, radar systems, and software. BEL reported Q3 revenue of ₹7,122 crore, up…

Adani Enterprises has secured NCLT approval for its resolution plan for Jaiprakash Associates, with the plan envisaging no recovery for equity shareholders due to inadequate…

India Glycols Ltd announces a ₹7.5 interim dividend per share for FY 2025-26. Shares of India Glycols Ltd ended marginally lower on Tuesday, March 17,…

Aurobindo Pharma announced that the US FDA classified its subsidiary Eugia Pharma’s unit-II in Bhiwadi as ‘Official Action Indicated’ after inspection. No business impact is…